Viewpoints

Novel Toxicity Examinations for Patients Treated With Targeted Therapies

Novel Toxicity Examinations for Patients Treated With Targeted Therapies

Instead of analyzing adverse events (AEs) in the traditional fashion, we ought to consider alternatives in this new era of personalized medicine.

Senescent Effects on Cancer Cells Are Context-dependent

Senescent Effects on Cancer Cells Are Context-dependent

The senescence-associated secretory phenotype can promote tumorigenesis under certain conditions, and may offer a target for senolytic therapy.

Bone Cancer News

Feature Articles

Research Is Expanding Into the Use of Interleukin-12 as an Anticancer Agent

Research Is Expanding Into the Use of Interleukin-12 as an Anticancer Agent

Recent research has indicated the potential for IL-12 therapy to be effective in combination with new and emerging biologics including other immunomodulatory drugs.

Managing Symptoms Is Key for Patients With Metastatic Cancer Who Continue to Work

Managing Symptoms Is Key for Patients With Metastatic Cancer Who Continue to Work

Patients with metastatic cancer who continue to work may need the income or access to health insurance or simply have the desire to work, yet they face a number of hurdles.

Bone Cancer Resources

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters